3',4'-Methylenedioxy-α-pyrrolidinopropiophenone

Stimulant drug From Wikipedia, the free encyclopedia

3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a stimulant designer drug. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation ecstasy (MDMA) pills.[3] It shares a similar chemical structure with α-PPP and MDPV,[4][1][2] and has been shown to have reinforcing effects in rats.[5]

Routes of
administrationBy mouth, insufflation, vaporization, IV, rectal, sublingual
ATC code
  • None
Legal status
MetabolismHepatic[1][2]
Quick facts Clinical data, Routes ofadministration ...
MDPPP
Clinical data
Routes of
administration		By mouth, insufflation, vaporization, IV, rectal, sublingual
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic[1][2]
ExcretionPrimarily urine (renal)
Identifiers
  • (RS)-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H17NO3
Molar mass247.294 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • c3c1OCOc1ccc3C(=O)C(C)N2CCCC2
  • InChI=1S/C14H17NO3/c1-10(15-6-2-3-7-15)14(16)11-4-5-12-13(8-11)18-9-17-12/h4-5,8,10H,2-3,6-7,9H2,1H3
  • Key:NIYQOTCYXGXMPI-UHFFFAOYSA-N
Close

Metabolism

MDPPP appears to have a similar metabolic fate as MDPV.[2]

Legal status

As of October 2015 MDPPP is a controlled substance in China.[6]

See also

References

Related Articles

Wikiwand AI